EFFECT OF CV 205-502 IN HYPERPROLACTINAEMIC PATIENTS INTOLERANT OF BROMOCRIPTINE

被引：28

作者：

NEWMAN, CB ^{[1
]}

HURLEY, AM ^{[1
]}

KLEINBERG, DL ^{[1
]}

机构：

[1] NYU MED CTR,DEPT MED,NEW YORK,NY 10016

来源：

CLINICAL ENDOCRINOLOGY | 1989年 / 31卷 / 04期

关键词：

D O I：

10.1111/j.1365-2265.1989.tb01263.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：391 / 400

页数：10

共 25 条

[1] PARENTERAL BROMOCRIPTINE IN THE TREATMENT OF HORMONALLY ACTIVE PITUITARY-TUMORS [J].

BENKER, G ;

GIESHOFF, B ;

FREUNDLIEB, O ;

WINDECK, R ;

SCHULTE, HM ;

LANCRANJAN, I ;

REINWEIN, D .

CLINICAL ENDOCRINOLOGY, 1986, 24 (05) :505-513

[2] GALACTORRHEA - SUCCESSFUL TREATMENT WITH REDUCTION OF PLASMA PROLACTIN LEVELS BY BROM-ERGOCRYPTINE [J].

BESSER, GM ;

MCNEILLY, AS ;

EDWARDS, CRW ;

PARKE, L ;

FORSYTH, IA .

BRITISH MEDICAL JOURNAL, 1972, 3 (5828) :669-&

[3]

BESSER GM, 1976, POSTGRAD MED J, V52, P64

[4] SIZE-REDUCTION OF MACROPROLACTINOMAS BY BROMOCRIPTINE OR LISURIDE TREATMENT [J].

CHIODINI, P ;

LIUZZI, A ;

COZZI, R ;

VERDE, G ;

OPPIZZI, G ;

DALLABONZANA, D ;

SPELTA, B ;

SILVESTRINI, F ;

BORGHI, G ;

LUCCARELLI, G ;

RAINER, E ;

HOROWSKI, R .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (04) :737-743

[5] EFFECTS OF A NEW LONG-ACTING FORM OF BROMOCRIPTINE ON TUMOROUS HYPERPROLACTINEMIA [J].

CICCARELLI, E ;

GHIGO, E ;

MAZZA, E ;

ANDREIS, M ;

MASSARA, F ;

LANCRANJAN, I ;

CAMANNI, F .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1987, 10 (02) :179-182

[6] EFFECT OF THE NEW ERGOT DERIVATIVE TERGURIDE ON PLASMA PRL AND GH LEVELS IN PATIENTS WITH PATHOLOGICAL HYPERPROLACTINEMIA OR ACROMEGALY [J].

DALLABONZANA, D ;

LIUZZI, A ;

OPPIZZI, G ;

VERDE, G ;

CHIODINI, PG ;

DOROW, R ;

HOROWSKI, R .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1985, 8 (02) :147-151

[7]

DELPOZO E, 1972, J CLIN ENDOCR METAB, V35, P768, DOI 10.1210/jcem-35-5-768

[8] TREATMENT OF HUMAN HYPERPROLACTINEMIA WITH A NEW DOPAMINE AGONIST - CU-32085 (MESULERGIN) [J].

DEWAILLY, D ;

THOMAS, P ;

BUVAT, J ;

WEMEAU, JL ;

FOURLINNIE, JC ;

LEMAITRE, G ;

MAZZUCA, M ;

FOSSATI, P .

ACTA ENDOCRINOLOGICA, 1985, 110 (04) :433-439

[9] LONG-LASTING PROLACTIN-LOWERING EFFECT OF CABERGOLINE, A NEW DOPAMINE AGONIST, IN HYPERPROLACTINEMIC PATIENTS [J].

FERRARI, C ;

BARBIERI, C ;

CALDARA, R ;

MUCCI, M ;

CODECASA, F ;

PARACCHI, A ;

ROMANO, C ;

BOGHEN, M ;

DUBINI, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) :941-945

[10]

FLUCKIGER E, 1986, ENDOCRINOLOGY 85, P261

← 1 2 3 →